FI813331L - Foerfarande foer framstaellning av rent kristalliniskt p-toluensulfonsyrasalt av det antimikrobiella aemnet 1,1-dioxopenicillanoyloxymetyl-6-(d-alfa-amino-alfa-fenylacetamido - Google Patents

Foerfarande foer framstaellning av rent kristalliniskt p-toluensulfonsyrasalt av det antimikrobiella aemnet 1,1-dioxopenicillanoyloxymetyl-6-(d-alfa-amino-alfa-fenylacetamido

Info

Publication number
FI813331L
FI813331L FI813331A FI813331A FI813331L FI 813331 L FI813331 L FI 813331L FI 813331 A FI813331 A FI 813331A FI 813331 A FI813331 A FI 813331A FI 813331 L FI813331 L FI 813331L
Authority
FI
Finland
Prior art keywords
alpha
toluensulfonsyrasalt
kristalliniskt
antimicrobiella
aemnet
Prior art date
Application number
FI813331A
Other languages
English (en)
Finnish (fi)
Inventor
Wagn Ole Godtfredsen
Welf Von Daehne
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI813331L publication Critical patent/FI813331L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI813331A 1980-10-31 1981-10-23 Foerfarande foer framstaellning av rent kristalliniskt p-toluensulfonsyrasalt av det antimikrobiella aemnet 1,1-dioxopenicillanoyloxymetyl-6-(d-alfa-amino-alfa-fenylacetamido FI813331L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8035156 1980-10-31

Publications (1)

Publication Number Publication Date
FI813331L true FI813331L (fi) 1982-05-01

Family

ID=10517019

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813331A FI813331L (fi) 1980-10-31 1981-10-23 Foerfarande foer framstaellning av rent kristalliniskt p-toluensulfonsyrasalt av det antimikrobiella aemnet 1,1-dioxopenicillanoyloxymetyl-6-(d-alfa-amino-alfa-fenylacetamido

Country Status (26)

Country Link
US (1) US4831025A (sv)
JP (1) JPS57126493A (sv)
KR (1) KR870001982B1 (sv)
AT (1) AT373893B (sv)
AU (1) AU543870B2 (sv)
BE (1) BE890938A (sv)
CA (1) CA1180696A (sv)
CH (1) CH647527A5 (sv)
DE (1) DE3143219A1 (sv)
DK (1) DK154219C (sv)
ES (1) ES8206531A1 (sv)
FI (1) FI813331L (sv)
FR (1) FR2493322B1 (sv)
GB (1) GB2114969B (sv)
GR (1) GR75369B (sv)
IE (1) IE51640B1 (sv)
IL (1) IL64009A (sv)
IT (1) IT1193735B (sv)
LU (1) LU83727A1 (sv)
NL (1) NL8104938A (sv)
NO (1) NO813683L (sv)
NZ (1) NZ198622A (sv)
PH (1) PH17820A (sv)
PT (1) PT73913B (sv)
SE (1) SE452322B (sv)
ZA (1) ZA817091B (sv)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
PH20068A (en) * 1982-12-06 1986-09-18 Pfizer Process and intermediates for sultamicillin and analogs
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ES2161602B1 (es) * 1999-04-08 2003-02-16 Asturpharma S A Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
CA2400784C (en) * 2000-02-24 2009-05-19 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
WO2001062195A1 (en) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US7157095B2 (en) * 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
WO2004104022A2 (en) * 2003-05-16 2004-12-02 The General Hospital Corporation Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
WO2007004239A1 (en) * 2005-07-06 2007-01-11 Morepen Laboratories Limited New polymorphic form of sultamicillin tosylate and a process therefor
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2014014364A1 (en) 2012-07-17 2014-01-23 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
MY172561A (en) 2012-07-17 2019-12-03 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532222A (fr) * 1963-10-28 1968-07-12 Bristol Myers Co Procédé de préparation de dérivés de la pénicilline
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate

Also Published As

Publication number Publication date
ATA447781A (de) 1983-07-15
PH17820A (en) 1985-01-07
PT73913A (en) 1981-11-01
DK472181A (da) 1982-05-01
AU543870B2 (en) 1985-05-09
ES506751A0 (es) 1982-08-16
IE51640B1 (en) 1987-01-21
GR75369B (sv) 1984-07-13
AU7636581A (en) 1982-05-06
US4831025A (en) 1989-05-16
DK154219C (da) 1989-03-20
JPS57126493A (en) 1982-08-06
BE890938A (fr) 1982-04-30
GB2114969B (en) 1985-02-20
CA1180696A (en) 1985-01-08
KR830007671A (ko) 1983-11-04
ZA817091B (en) 1982-10-27
DE3143219C2 (sv) 1990-05-17
IL64009A0 (en) 1982-01-31
KR870001982B1 (ko) 1987-10-24
NZ198622A (en) 1985-07-12
DE3143219A1 (de) 1982-08-12
NO813683L (no) 1982-05-03
AT373893B (de) 1984-02-27
IT8168383A0 (it) 1981-10-23
FR2493322B1 (fr) 1986-06-13
CH647527A5 (de) 1985-01-31
DK154219B (da) 1988-10-24
IL64009A (en) 1984-09-30
SE452322B (sv) 1987-11-23
ES8206531A1 (es) 1982-08-16
SE8106404L (sv) 1982-05-01
LU83727A1 (fr) 1982-05-07
GB2114969A (en) 1983-09-01
NL8104938A (nl) 1982-05-17
PT73913B (en) 1984-05-29
JPH027957B2 (sv) 1990-02-21
IT1193735B (it) 1988-08-24
FR2493322A1 (fr) 1982-05-07
IE812361L (en) 1982-04-30

Similar Documents

Publication Publication Date Title
FI813331L (fi) Foerfarande foer framstaellning av rent kristalliniskt p-toluensulfonsyrasalt av det antimikrobiella aemnet 1,1-dioxopenicillanoyloxymetyl-6-(d-alfa-amino-alfa-fenylacetamido
FR2477145B1 (fr) 25-hydroxy-26, 26, 26, 27, 27, 27-hexafluorocholecalciferol
DK284481A (da) 10-(1,2-propadiennyl) steroider
FI812270L (fi) Antiinflammatoriska 4,5-diaryl-alfa-polyfluoralkyl-1h-imidazol-2-metanaminer
FI812094L (fi) Foerfarande foer silylering av organiska foereningar med 1,1,1-trimetyl-n-(trimetylsilyl)silanamin genom att katalysera med kvaevehaltiga foereningar
FI812803L (fi) Penisillanoyloximetyl penicillanat 1,1,1',1'-tetraoxid
FI811191L (fi) Antiinflammatoriska 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-metanaminer
DK155594C (da) 3,3-dimethyl-1-phenoxybutan-2-oler
FI811967L (fi) 2,3-bis-hydroxibenzylderivat
IT1136980B (it) "17-sostituiti solfonil-16,16-disostituiti androsteni"
IT1172389B (it) 2,2,2-trialogeno-1-(trialogenometil)etiliden-bis-benzen-tioli
FI813729L (fi) Nytt foerfarande foer framstaellning av 5,6,7,7a-tetrahydro-4h-tieno(3,2-c)-pyridin-2-onderivat
DE3175752D1 (de) 1,3-dihalopropan-2-ols
FI810242L (fi) 1,3-diformyloxi-2-brom-nitropropan
IT1189011B (it) 1,4;3,6-dinanidro-2,5-diazido-2,5-dideossi-esitoli
FI832262A0 (fi) Foerfarande foer framstaellning av 1-alkyl- eller 1,4-dialkyl-1h-pyrrol-2-aettiksyraestrar
FI831073A0 (fi) Foerfarande foer framstaellning av flerskiktbyggda, sjaelvbaerande taeckningsytor, saerskilt av ettbaotskrovskal
DK157002C (da) 1,3-dihalogenpropan-2-oler
DE3175756D1 (de) 3,5,12-trihydroxy-6,11-dioxonaphthacenes
IT1141257B (it) Chinazoline 2,4,6,7-tetrasostituite
IT8049853A0 (it) 6-alfa-fluoro-prednisolone 17,21diesteri
DE3134423A1 (de) Ciferol 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
FI822823A0 (fi) 2,9-dioksatrisyklo-(4,3,1,0 )-dekaner
FI824154A0 (fi) Foerfarande foer framstaellning av syrehaltiga 3,7a-diazacyklohepta/j,k/fluorenderivat
FI822850A0 (fi) Foerfarande foer installering av skivor, i synnerhet cellplastskivor, i vaexthus

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S (LOEVENS KEMIS